COVID-19: laboratory evaluations of serological assays
PHE has undertaken a number of rapid evaluations of commercial serological assays for their suitability for detecting the production of COVID-19 antibodies.
Documents
Details
Please refer to the position statement and conflict of interest statement regarding these evaluations.
Updates to this page
Last updated 26 May 2021 + show all updates
-
Added Evaluation of Roche Elecsys Anti-SARS-CoV-2 S serology assay.
-
Uploaded new version of Supporting information for the PHE commercial serology assay evaluations.
-
Added Evaluation of Siemens Atellica-IM IgG (sCOVG) SARS-CoV-2 serology assay.
-
Added Beckman Coulter Access Anti-SARS-CoV-2 IgG assay and supporting information for the PHE commercial serology assay evaluations.
-
Added 'Evaluation of Siemens Atellica-IM Total (COV2T) SARS-CoV-2 serology assay for the detection of anti-SARS-CoV-2 total antibodies' and 'Evaluation of the Ortho Clinical Diagnostics Vitros Immunodiagnostic Products Anti-SARS-CoV-2 Totalserology assay for the detection of anti-SARS-CoV-2 antibodies'.
-
Added 'Evaluation of DiaSorin LIAISON SARS-CoV-2 S1/S2 IgG serology assay for the detection of anti-SARS-CoV-2 antibodies' and 'Evaluation of the Euroimmun Anti-SARS-CoV-2 ELISA (IgG) serology assay for the detection of anti-SARS-CoV-2 antibodies'.
-
Updated Evaluation of Roche Elecsys Anti-SARS-CoV-2 serology assay for the detection of anti-SARS-CoV-2 antibodies.
-
Updated Evaluation of Abbott SARS-CoV-2 IgG for the detection of anti-SARS-CoV-2 antibodies.
-
Added Evaluation of the Ortho Clinical Diagnostics Vitros Immunodiagnostic document.
-
Added updated Abbott and Roche evaluation reports.
-
Updated reports.
-
First published.